Table 4.
Plasma HCG (IU/L) | NO (µM/g wet weight placental tissues) | TBARS (µM/g wet weight placental tissues) | GSH (µM/mg protein in placental tissue extract) | SOD (U/mg protein in placental tissue extract) | Bcl-2 (ng/ protein in placental tissue extract) | Caspase-3 (ng/ protein in placental tissue extract) | ||
---|---|---|---|---|---|---|---|---|
PCB28 (µg/L) | r | − 0.707 | 0.696 | 0.889 | − 0.775 | − 0.682 | − 0.636 | 0.743 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
PCB52 (µg/L) | r | − 0.519 | 0.494 | 0.743 | − 0.631 | − 0.481 | − 0.420 | 0.534 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | 0.002 | < 0.001 | |
PCB118 (µg/L) | r | − 0.821 | 0.847 | 0.942 | − 0.845 | − 0.820 | − 0.799 | 0.888 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
PCB180 (µg/L) | r | − 0.745 | 0.759 | 0.890 | − 0.765 | − 0.723 | − 0.699 | 0.802 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
DDE (µg/L) | r | − 0.616 | 0.602 | 0.881 | − 0.739 | − 0.576 | − 0.520 | 0.650 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
Dieldrin (µg/L) | r | − 0.635 | 0.628 | 0.837 | − 0.706 | − 0.598 | − 0.548 | 0.666 |
P | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | < 0.001 | |
Ethion (µg/L) | r | − 0.341 | 0.309 | 0.513 | − 0.434 | − 0.318 | − 0.264 | 0.346 |
P | 0.013 | 0.026 | < 0.001 | 0.001 | 0.022 | 0.059 | 0.012 |
PCB, polychlorinated biphenyl; DDT, dichlorodiphenyltrichloroethane; HCG, human chorionic gonadotropin; NO., nitric oxide; TBARS, thiobarbituric acid reactive substances; GSH, glutathione; SOD, superoxide dismutase activity; BcI-2, lymphoma 2 protein; Caspase-3, cysteine-dependent aspartate specific protease; r, Pearson’s correlation coefficient; p, p-Value.